GO:0042285 xylosyltransferase activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0042285 (xylosyltransferase activity) is a molecular function in which an enzyme transfers a xylose residue from UDP-xylose onto an acceptor substrate, typically a protein or oligosaccharide.
• The best-characterized human xylosyltransferases are XYLT1 and XYLT2, which initiate glycosaminoglycan chain formation on proteoglycans and are measured by selective activity assays.
• Xylosyltransferase activity is not limited to proteoglycan biosynthesis; GXYLT1/2 and XXYLT1 use xylose to modify Notch EGF repeats, and plant XXT5 xylosylates xyloglucan.
• Serum xylosyltransferase-I activity has been proposed as a biomarker for postmenopausal osteoporosis and for fibrotic lung injury.
• XYLT1 can activate NF-kB signaling and promote metastasis in early-stage lung adenocarcinoma, linking xylosyltransferase activity to cancer progression.
• Xylosyltransferase 2 deficiency alters organ homeostasis in animal models, showing that these enzymes have systemic physiological roles beyond matrix assembly.
Description
Xylosyltransferase activity (GO:0042285) is a molecular function that catalyzes the transfer of xylose from UDP-xylose to an acceptor molecule. In humans, this activity is best known for initiating the tetrasaccharide linkage region that attaches glycosaminoglycan chains to serine residues of proteoglycans, a step performed by XYLT1 and XYLT2. Because this reaction is the first committed step in proteoglycan biosynthesis, its measurement and manipulation are central to matrix biology, developmental biology, and disease research. Beyond proteoglycans, xylosyltransferase activity also modifies Notch receptors through GXYLT1, GXYLT2, and XXYLT1, and it participates in plant cell wall polysaccharide synthesis through enzymes such as XXT5. This breadth makes GO:0042285 relevant to researchers studying connective tissue disorders, fibrosis, cancer, and glycobiology. The availability of selective activity assays using acceptor peptides and mass spectrometry has made it possible to quantify XYLT1 and XYLT2 separately in biological samples.
xylosyltransferase activity At A Glance
| GO ID | GO:0042285 |
|---|---|
| GO term | xylosyltransferase activity |
| Ontology | molecular_function |
| Synonym | None listed in QuickGO |
| Major function | Transfer of xylose from UDP-xylose to protein or oligosaccharide acceptors |
| Representative human genes | XYLT1, XYLT2, GXYLT1, GXYLT2, XXYLT1 |
| Representative plant gene | XXT5 (xyloglucan xylosyltransferase 5) |
| Common assay | UPLC-MS/MS or SPE-UPLC-MS/MS with acceptor peptides |
| Disease relevance | Osteoporosis, lung adenocarcinoma, organ homeostasis, lung injury |
What Is GO:0042285?
Xylosyltransferase activity (GO:0042285) is the catalytic function of an enzyme that transfers a xylose monosaccharide from a donor such as UDP-xylose to an acceptor substrate. In the context of proteoglycan biosynthesis, the acceptor is a specific serine residue within a consensus sequence of a core protein, and the added xylose becomes the first sugar of the glycosaminoglycan linkage region. The same catalytic activity can also act on oligosaccharide acceptors, as shown for xyloglucan xylosyltransferase 5 in plants. Thus, GO:0042285 describes a glycosyltransferase function defined by xylose transfer rather than by a single gene or pathway.
Why Is xylosyltransferase activity Important in Cell Biology?
Xylosyltransferase activity is important because it controls the first step of glycosaminoglycan attachment to proteoglycans, a modification that determines the structure and function of extracellular matrix components throughout the body. Dysregulation of this activity has been linked to skeletal disease, fibrotic tissue remodeling, and cancer progression, making it a candidate biomarker and therapeutic target. In addition, the same enzymatic activity participates in Notch signaling and plant cell wall biosynthesis, so it is studied across multiple kingdoms and disciplines.
• Initiates glycosaminoglycan chain assembly on proteoglycans, affecting matrix structure and cell signaling.
• Serum XYLT1 activity is under investigation as a biomarker for postmenopausal osteoporosis.
• XYLT1 promotes NF-kB signaling and metastasis in early-stage lung adenocarcinoma.
• XYLT2 deficiency alters organ homeostasis in animal models, indicating systemic roles.
• Xylosyltransferase activity increases in bleomycin-induced lung injury and correlates with proteoglycan deposition.
• GXYLT1/2 and XXYLT1 modify Notch EGF repeats, connecting xylosylation to developmental signaling.
• Plant XXT5 xylosylates xyloglucan, a major hemicellulose in cell walls.
• Selective activity assays enable separate quantification of XYLT1 and XYLT2 in clinical samples.
• The enzymatic reaction is a potential target for modulating proteoglycan-related pathologies.
• Conserved across species, xylosyltransferase activity provides a model for studying glycosyltransferase mechanism.
Molecular Mechanism of xylosyltransferase activity
Substrate recognition and donor specificity
In simple terms: The enzyme picks up a xylose sugar from a donor molecule and attaches it to a specific spot on a target molecule.
Xylosyltransferases use UDP-xylose as the donor substrate and transfer xylose to an acceptor, which can be a serine residue in a proteoglycan core protein or an oligosaccharide. For XYLT1 and XYLT2, the acceptor is typically a serine within a consensus sequence, and the reaction initiates the glycosaminoglycan linkage region. In plants, XXT5 transfers xylose to xyloglucan oligosaccharides, demonstrating that acceptor specificity varies across enzymes.
Catalytic transfer and linkage formation
In simple terms: The enzyme forms a chemical bond between xylose and the target, creating a new sugar linkage.
The catalytic step results in the formation of a xylose-acceptor linkage, which for proteoglycans is a xylose-serine bond. This reaction is the first committed step in glycosaminoglycan biosynthesis, and its product serves as the primer for subsequent galactose and glucuronic acid additions. In Notch modification, GXYLT1/2 and XXYLT1 add xylose to EGF repeats, forming a distinct linkage that affects receptor function.
Enzyme families and isoforms
In simple terms: Different enzymes can perform the same basic reaction but on different targets.
Human xylosyltransferase activity is represented by XYLT1 and XYLT2, which share the ability to xylosylate proteoglycan core proteins but differ in tissue distribution and regulation. GXYLT1, GXYLT2, and XXYLT1 form a separate family that xylosylates Notch EGF repeats. Plant XXT5 belongs to a distinct family that acts on xyloglucan.
Assay and detection of activity
In simple terms: Scientists measure how much xylose is transferred to know how active the enzyme is.
Selective activity assays use specific acceptor peptides and mass spectrometry to quantify XYLT1 and XYLT2 activity separately. A novel SPE-UPLC-MS/MS assay allows simultaneous quantification of both enzymes in biological samples. These methods have been applied to measure serum activity in osteoporosis and to study enzyme kinetics.
Regulation by substrate availability and signaling
In simple terms: The reaction can be turned up or down depending on the cell's needs and signals.
Xylosyltransferase activity can be regulated by the availability of UDP-xylose and by the expression levels of the enzymes. In lung injury, xylosyltransferase activity increases along with proteoglycan deposition, suggesting regulation by inflammatory signals. XYLT1 can also activate NF-kB signaling, indicating a feedback loop between xylosylation and intracellular pathways.
Key Genes Involved in GO:0042285 xylosyltransferase activity
The following genes encode enzymes with xylosyltransferase activity or are directly involved in its biological outcomes.
| Gene | Major Role | Research Relevance |
|---|---|---|
| XYLT1 | Initiates glycosaminoglycan chain formation on proteoglycans; activates NF-kB signaling | Cancer metastasis, osteoporosis biomarker, proteoglycan biosynthesis |
| XYLT2 | Initiates glycosaminoglycan chain formation; maintains organ homeostasis | Organ homeostasis, proteoglycan disorders, enzyme assays |
| GXYLT1 | Xylosylates Notch EGF repeats | Notch signaling, developmental biology |
| GXYLT2 | Xylosylates Notch EGF repeats | Notch signaling, developmental biology |
| XXYLT1 | Xylosylates Notch EGF repeats | Notch signaling, glycosyltransferase mechanism |
| XXT5 | Xylosylates xyloglucan in plant cell walls | Plant cell wall biosynthesis |
| B4GALT7 | Adds galactose to xylose in the linkage region | Proteoglycan biosynthesis (downstream of xylosylation) |
| B3GALT6 | Adds galactose to the linkage region | Proteoglycan biosynthesis |
| B3GAT3 | Adds glucuronic acid to complete the linkage region | Proteoglycan biosynthesis |
| EXT1 | Polymerizes heparan sulfate chains after linkage | Heparan sulfate biosynthesis |
| EXT2 | Polymerizes heparan sulfate chains after linkage | Heparan sulfate biosynthesis |
| CHSY1 | Polymerizes chondroitin sulfate chains after linkage | Chondroitin sulfate biosynthesis |
| CSGALNACT1 | Adds GalNAc to chondroitin sulfate | Chondroitin sulfate biosynthesis |
| CSGALNACT2 | Adds GalNAc to chondroitin sulfate | Chondroitin sulfate biosynthesis |
| FAM20B | Phosphorylates xylose in the linkage region | Linkage region modification |
| SLC35B4 | Transports UDP-xylose into the Golgi | Donor substrate supply |
| UGDH | Synthesizes UDP-glucuronate, a precursor of UDP-xylose | Donor substrate supply |
| UXS1 | Converts UDP-glucuronate to UDP-xylose | Donor substrate supply |
How Is xylosyltransferase activity Regulated?
Xylosyltransferase activity is regulated at multiple levels. The availability of the donor substrate UDP-xylose, which is synthesized by UGDH and UXS1 and transported into the Golgi by SLC35B4, directly influences reaction rates. Expression levels of XYLT1 and XYLT2 vary by tissue and developmental stage, and their activity can be induced by inflammatory signals in lung injury. In cancer, XYLT1 activates NF-kB signaling, suggesting that downstream pathways can feed back on xylosyltransferase function. Additionally, XYLT2 deficiency alters organ homeostasis, indicating that systemic regulatory mechanisms compensate or respond to loss of activity.
xylosyltransferase activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| XYLT1 | Postmenopausal osteoporosis; lung adenocarcinoma metastasis | XYLT1 knockout or overexpression in osteoblast and lung cancer cell lines |
| XYLT2 | Organ homeostasis defects | XYLT2 knockout mouse or zebrafish |
| XYLT1/XYLT2 | Lung injury and fibrosis | Bleomycin-induced lung injury rat model |
| GXYLT1/XXYLT1 | Notch signaling dysregulation | Notch reporter cell lines with GXYLT1/XXYLT1 knockout |
| XXT5 | Plant cell wall defects | Arabidopsis xxt5 mutants |
Xylosyltransferase activity in osteoporosis
Serum xylosyltransferase-I activity has been proposed as a promising biomarker for postmenopausal osteoporosis. Because XYLT1 initiates proteoglycan biosynthesis in bone matrix, changes in its activity may reflect altered bone turnover. Measuring XYLT1 activity could therefore aid in identifying individuals at risk for osteoporosis.
Xylosyltransferase activity in lung adenocarcinoma
XYLT1 activates NF-kB signaling to promote metastasis of early-stage lung adenocarcinoma. This links xylosyltransferase activity directly to cancer progression and suggests that inhibiting XYLT1 could reduce metastatic spread. The mechanism involves downstream signaling rather than only matrix modification.
Xylosyltransferase activity in lung injury and fibrosis
In bleomycin-induced lung injury in rats, xylosyltransferase activity increases along with proteoglycan deposition. This suggests that xylosyltransferase activity contributes to fibrotic remodeling and may serve as a marker of lung injury.
Xylosyltransferase activity in organ homeostasis
Xylosyltransferase 2 deficiency alters organ homeostasis in animal models, indicating that XYLT2 activity is required for normal organ function. This broadens the physiological importance of xylosyltransferase activity beyond skeletal and lung tissues.
From xylosyltransferase activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of XYLT1 reduce proteoglycan biosynthesis? | XYLT1 knockout cell line (e.g., HEK293 or chondrocytes) |
| Does a point mutation in XYLT1 abolish catalytic activity? | Point-mutation knock-in of catalytic residues in XYLT1 |
| Can tagged XYLT1 be used to track subcellular localization? | Knock-in of fluorescent or epitope tag at the endogenous XYLT1 locus |
| Does overexpression of XYLT1 promote metastasis? | XYLT1 overexpression in lung adenocarcinoma cell lines |
| Does XYLT2 deficiency alter organ homeostasis? | XYLT2 knockout mouse model |
| Does GXYLT1 xylosylate Notch in cells? | GXYLT1 knockout or overexpression in Notch reporter cells |
How to Study the xylosyltransferase activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| UPLC-MS/MS activity assay | Xylosyltransferase activity using acceptor peptides | Quantification of XYLT1/XYLT2 in serum or cell lysates |
| SPE-UPLC-MS/MS | Simultaneous XYLT1 and XYLT2 activity | Clinical biomarker studies |
| CRISPR knockout | Loss of gene function | Determining requirement for xylosyltransferase activity |
| Overexpression | Gain of function | Testing oncogenic potential of XYLT1 |
| Site-directed mutagenesis | Catalytic residue function | Mapping active site of xylosyltransferases |
| Immunoblotting | Protein expression levels | Correlating expression with activity |
| Immunofluorescence | Subcellular localization | Golgi localization of XYLT1/2 |
| Plant mutant analysis | Xyloglucan xylosylation | Cell wall phenotyping in Arabidopsis |
Selective activity assays using mass spectrometry
UPLC-MS/MS and SPE-UPLC-MS/MS assays with specific acceptor peptides allow selective quantification of XYLT1 and XYLT2 activity in biological samples. These methods are sensitive and can be used to measure serum activity in clinical studies.
Genetic knockout and knockdown
Knockout of XYLT1, XYLT2, or GXYLT1/2 using CRISPR or RNAi can reveal their contributions to proteoglycan biosynthesis and signaling. Such models are essential for linking enzyme activity to phenotype.
Biochemical characterization of enzyme kinetics
Recombinant enzymes can be assayed with synthetic acceptors to determine kinetic parameters and substrate specificity. This approach has been used for GXYLT1/2, XXYLT1, and XXT5.
Expression and localization studies
Antibodies and tagged constructs can be used to detect XYLT1 and XYLT2 expression and Golgi localization. Changes in expression in disease models can be correlated with activity measurements.
How CRISPR Can Be Used to Study GO:0042285 xylosyltransferase activity
Knockout
CRISPR knockout of XYLT1 or XYLT2 can abolish xylosyltransferase activity, leading to loss of glycosaminoglycan chains on proteoglycans. Such models are used to study the consequences of deficient proteoglycan biosynthesis in organ homeostasis and cancer.
Point Mutation
Point mutations in catalytic residues of XYLT1 or XYLT2 can be introduced to dissect the enzymatic mechanism without deleting the entire protein. These models help distinguish catalytic activity from non-enzymatic functions.
Knock-in
Knock-in of epitope or fluorescent tags at the endogenous XYLT1 locus allows tracking of enzyme localization and interaction partners. This approach preserves endogenous regulation of expression.
Overexpression
Overexpression of XYLT1 in lung adenocarcinoma cells promotes NF-kB signaling and metastasis, providing a gain-of-function model. Overexpression can also be used to study substrate saturation and downstream effects.
How EDITGENE Supports xylosyltransferase activity Research
Researchers studying xylosyltransferase activity-related genes often need to determine whether a candidate gene is causally involved in proteoglycan biosynthesis, signaling, or disease phenotypes. EDITGENE provides a comprehensive suite of CRISPR-based services to create precisely engineered cell and animal models for such investigations.
Contact EDITGENE today to design your custom CRISPR model for xylosyltransferase activity research.
Related Products
| Product name | Cat.No. | Species | Gene ID | |
|---|---|---|---|---|
| LARGE1 Knockout HEK293 Cell Line | EDJ-KQ6508 | Human | 9215 | Details Get a Quote |
| LARGE2 Knockout HEK293 Cell Line | EDJ-KQ7655 | Human | 120071 | Details Get a Quote |
| LARGE2 Knockout A-549 Cell Line | EDJ-KQ33011 | Human | 120071 | Details Get a Quote |
| LARGE2 Knockout HCT 116 Cell Line | EDJ-KQ33012 | Human | 120071 | Details Get a Quote |
| LARGE1 Knockout A-549 Cell Line | EDJ-KQ30653 | Human | 9215 | Details Get a Quote |
| LARGE2 Knockout HeLa Cell Line | EDJ-KQ31680 | Human | 120071 | Details Get a Quote |
Displaying Records 1 To 6 Of 6 Records
Frequently Asked Questions About xylosyltransferase activity
What is xylosyltransferase activity?
Xylosyltransferase activity (GO:0042285) is the enzymatic transfer of xylose from UDP-xylose to an acceptor molecule, such as a serine residue on a proteoglycan or an oligosaccharide.
What genes are involved in xylosyltransferase activity?
Key human genes include XYLT1, XYLT2, GXYLT1, GXYLT2, and XXYLT1; in plants, XXT5 is a representative gene.
What diseases are linked to xylosyltransferase activity?
It has been linked to postmenopausal osteoporosis, lung adenocarcinoma metastasis, lung injury, and organ homeostasis defects.
How is xylosyltransferase activity measured?
Selective UPLC-MS/MS or SPE-UPLC-MS/MS assays using specific acceptor peptides can quantify XYLT1 and XYLT2 activity.
Is xylosyltransferase activity a molecular function or biological process?
It is a molecular function (GO:0042285) that contributes to biological processes such as proteoglycan biosynthesis and Notch signaling.
What is the role of XYLT1 in cancer?
XYLT1 activates NF-kB signaling to promote metastasis of early-stage lung adenocarcinoma.
Can xylosyltransferase activity be used as a biomarker?
Serum xylosyltransferase-I activity is a promising biomarker for postmenopausal osteoporosis.
What is the difference between XYLT1 and XYLT2?
Both initiate glycosaminoglycan chain formation, but they differ in tissue distribution and regulation; XYLT2 deficiency alters organ homeostasis.
Do plants have xylosyltransferase activity?
Yes, xyloglucan xylosyltransferase 5 (XXT5) in plants xylosylates xyloglucan, a cell wall polysaccharide.
How can CRISPR help study xylosyltransferase activity?
CRISPR knockout, point mutation, knock-in, and overexpression models allow researchers to test the causal role of xylosyltransferases in cells and animals.
Conclusion
Xylosyltransferase activity (GO:0042285) is a conserved enzymatic function that initiates glycosaminoglycan biosynthesis and modifies signaling receptors, with broad implications for skeletal health, cancer, and organ function. Selective activity assays and CRISPR models have advanced our understanding of its regulation and disease relevance. Continued research using precise genetic tools will clarify how this activity can be targeted therapeutically.
References
- 1. Nishihara S et al.. 2021. Assay of glucoside α1,3-xylosyltransferase 1/2 (GXYLT1/2) and xyloside α1,3-xylosyltransferase 1 (XXYLT1) xylosyltransferase activity.. PMID: 37590680
- 2. Witt A et al.. 2026. Xylosyltransferase-I serum activity is a promising biomarker for postmenopausal osteoporosis.. Sci Rep 16(1) PMID: 42624941
- 3. Han J et al.. 2025. The Glycosyltransferase XYLT1 Activates NF-κB Signaling to Promote Metastasis of Early-Stage Lung Adenocarcinoma.. Cancer Res 85(9):1628-1643 PMID: 39992715
- 4. Kleine A et al.. 2024. A novel SPE-UPLC-MS/MS-based assay for the selective, simultaneous quantification of xylosyltransferase-I and -II activity.. Biochimie 218:127-136 PMID: 37689257
- 5. Ferencz B et al.. 2020. Xylosyltransferase 2 deficiency and organ homeostasis.. Glycoconj J 37(6):755-765 PMID: 32965647
- 6. Koslowski R et al.. 2001. Changes in xylosyltransferase activity and in proteoglycan deposition in bleomycin-induced lung injury in rat.. Eur Respir J 18(2):347-56 PMID: 11529295
- 7. Culbertson AT et al.. 2016. Enzymatic Activity of Xyloglucan Xylosyltransferase 5.. Plant Physiol 171(3):1893-904 PMID: 27208276
- 8. Fischer B et al.. 2021. Development of a xylosyltransferase-I-selective UPLC MS/MS activity assay using a specific acceptor peptide.. Biochimie 184:88-94 PMID: 33609631
